HK Stock MarketDetailed Quotes

02552 HUA MEDICINE-B

Watchlist
  • 1.590
  • 0.0000.00%
Not Open Apr 25 16:09 CST
1.68BMarket Cap-7194P/E (TTM)

HUA MEDICINE-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
335.31%76.61M
--70.33M
--17.6M
----
----
----
----
----
----
----
Operating income
335.31%76.61M
70.33M
17.6M
Cost of sales
-295.92%-39.24M
---26.28M
---9.91M
----
----
----
----
----
----
----
Operating expenses
-295.92%-39.24M
-26.28M
-9.91M
Gross profit
386.07%37.37M
44.05M
7.69M
Selling expenses
-419.64%-79.76M
---52.92M
---15.35M
----
----
----
----
----
----
----
Administrative expenses
4.45%-124.15M
21.18%-54.02M
3.64%-129.93M
-7.90%-68.54M
3.75%-134.84M
1.14%-63.52M
4.43%-140.08M
13.46%-64.25M
-46.00%-146.58M
-129.36%-74.24M
Research and development expenses
-32.43%-171.54M
1.78%-71M
30.67%-129.53M
26.23%-72.29M
15.44%-186.84M
12.71%-97.98M
31.36%-220.96M
32.58%-112.25M
-19.64%-321.9M
-74.00%-166.5M
Special items of operating profit
100.27%134.74M
24.51%47.32M
59,115.79%67.28M
2,219.80%38.01M
99.59%-114K
-133.87%-1.79M
-162.76%-27.69M
-1.51%5.29M
-40.48%44.13M
-21.28%5.37M
Operating profit
-1.74%-203.33M
15.80%-86.57M
37.90%-199.84M
37.04%-102.81M
17.22%-321.78M
4.62%-163.29M
8.39%-388.74M
27.26%-171.21M
-43.69%-424.36M
-94.15%-235.37M
Financing cost
-115.63%-7.91M
-95.51%-3.53M
7.16%-3.67M
9.70%-1.81M
10.15%-3.95M
11.04%-2M
-384.67%-4.4M
-1,641.86%-2.25M
74.34%-907K
97.05%-129K
Earning before tax
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
88.20%-425.27M
84.37%-235.5M
After-tax profit from continuing operations
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
88.20%-425.27M
84.37%-235.5M
Earning after tax
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
88.20%-425.27M
84.37%-235.5M
Profit attributable to shareholders
-3.80%-211.23M
13.88%-90.1M
37.52%-203.51M
36.71%-104.62M
17.14%-325.73M
4.71%-165.29M
7.56%-393.13M
26.35%-173.46M
88.20%-425.27M
84.36%-235.5M
Basic earnings per share
-4.76%-0.22
18.18%-0.09
38.24%-0.21
35.29%-0.11
17.07%-0.34
5.56%-0.17
8.89%-0.41
28.00%-0.18
95.53%-0.45
98.16%-0.25
Diluted earnings per share
-4.76%-0.22
18.18%-0.09
38.24%-0.21
35.29%-0.11
17.07%-0.34
5.56%-0.17
8.89%-0.41
28.00%-0.18
95.53%-0.45
98.16%-0.25
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 335.31%76.61M--70.33M--17.6M----------------------------
Operating income 335.31%76.61M70.33M17.6M
Cost of sales -295.92%-39.24M---26.28M---9.91M----------------------------
Operating expenses -295.92%-39.24M-26.28M-9.91M
Gross profit 386.07%37.37M44.05M7.69M
Selling expenses -419.64%-79.76M---52.92M---15.35M----------------------------
Administrative expenses 4.45%-124.15M21.18%-54.02M3.64%-129.93M-7.90%-68.54M3.75%-134.84M1.14%-63.52M4.43%-140.08M13.46%-64.25M-46.00%-146.58M-129.36%-74.24M
Research and development expenses -32.43%-171.54M1.78%-71M30.67%-129.53M26.23%-72.29M15.44%-186.84M12.71%-97.98M31.36%-220.96M32.58%-112.25M-19.64%-321.9M-74.00%-166.5M
Special items of operating profit 100.27%134.74M24.51%47.32M59,115.79%67.28M2,219.80%38.01M99.59%-114K-133.87%-1.79M-162.76%-27.69M-1.51%5.29M-40.48%44.13M-21.28%5.37M
Operating profit -1.74%-203.33M15.80%-86.57M37.90%-199.84M37.04%-102.81M17.22%-321.78M4.62%-163.29M8.39%-388.74M27.26%-171.21M-43.69%-424.36M-94.15%-235.37M
Financing cost -115.63%-7.91M-95.51%-3.53M7.16%-3.67M9.70%-1.81M10.15%-3.95M11.04%-2M-384.67%-4.4M-1,641.86%-2.25M74.34%-907K97.05%-129K
Earning before tax -3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M88.20%-425.27M84.37%-235.5M
After-tax profit from continuing operations -3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M88.20%-425.27M84.37%-235.5M
Earning after tax -3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M88.20%-425.27M84.37%-235.5M
Profit attributable to shareholders -3.80%-211.23M13.88%-90.1M37.52%-203.51M36.71%-104.62M17.14%-325.73M4.71%-165.29M7.56%-393.13M26.35%-173.46M88.20%-425.27M84.36%-235.5M
Basic earnings per share -4.76%-0.2218.18%-0.0938.24%-0.2135.29%-0.1117.07%-0.345.56%-0.178.89%-0.4128.00%-0.1895.53%-0.4598.16%-0.25
Diluted earnings per share -4.76%-0.2218.18%-0.0938.24%-0.2135.29%-0.1117.07%-0.345.56%-0.178.89%-0.4128.00%-0.1895.53%-0.4598.16%-0.25
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg